People whose weight repeatedly went down and back up over four years lost nearly four times as much thigh muscle as people whose weight stayed steady, and they ended the period weighing about the same as when they started.
That is the central finding of an imaging study of 1,433 middle-aged adults, published in Radiology by a team from the University of California, San Francisco, and described in a UCSF release.
The number that matters: weight cyclers lost about 3.7% of thigh muscle volume over 48 months, compared with about 1% among people whose weight remained relatively stable.
Two clarifications belong immediately. This is an observational study, not a trial, so it shows an association rather than proof that weight cycling caused the muscle loss. And nobody in it was taking a GLP-1 medication, which matters given how the finding is being framed elsewhere.
What the MRI Study Measured
The researchers drew on the Osteoarthritis Initiative, a long-running, NIH-funded cohort of adults at elevated risk for knee osteoarthritis. That is a specific population, not a general sample of American adults.
Participants received MRI scans over four years. Using artificial intelligence to analyze the images, the team measured thigh muscle volume, fat located within the muscle, and fat surrounding the knee. Direct imaging is the methodological advance here, since most weight-cycling research has relied on scales, body-composition estimates, or self-reported dieting history.
The 3.7% versus 1% gap held after the researchers accounted for age, sex, baseline body mass index, physical activity, diet, and other health factors. The published conclusion states that among participants who maintained stable weight over 48 months, “weight cycling was associated with an increased loss of MRI-based thigh muscle volume.”
Notably, the team found no evidence of a difference between groups in the change in intermuscular fat proportion. The signal was in muscle volume, not fat infiltration.
Why the Muscle Did Not Come Back
The detail driving the coverage is directional. Weight came back. Muscle did not.
“When people’s weight cycled, they lost tremendous amounts of muscle along with the fat,” said Thomas Link, MD, PhD, professor of radiology, who led the study with co-first authors Adrian A. Marth, MD, and Gabby Joseph, PhD. He noted the muscle was not regained.
The mechanism is plausible and long suspected. Weight lost through calorie restriction includes lean tissue as well as fat, and regain is more efficiently deposited as fat than as muscle unless resistance training and adequate protein intake are part of the process. Repeat that cycle several times and the composition of a stable-looking body weight shifts.
The illustrative case UCSF released is striking but is a single participant, not a study result: one 62-year-old man’s thigh muscle volume fell 16% over 48 months while his BMI dropped only 1.6%. It shows how invisible this can be on a bathroom scale.
Worth stating carefully: the study followed people for four years. It did not establish that the loss is permanent, only that it had not reversed within that window.
The GLP-1 Question the Study Did Not Answer
This study is being widely presented as a warning about weight-loss drugs. It is not one, and the distinction matters for anyone currently taking these medications.
No participant was on a GLP-1 medication. Link’s own framing was that the insight addresses a question likely to grow in importance as more people start and stop weight-loss therapies, which is a hypothesis about relevance, not a finding about the drugs.
That said, the question is legitimate. People do stop and restart GLP-1s because of cost, coverage changes and side effects, and that pattern resembles weight cycling. MedicalDaily has previously reported on concerns about muscle loss and malnutrition in adults over 65 taking GLP-1 drugs and on the absence of muscle, bone and nutrition screening requirements in the Medicare GLP-1 Bridge program.
What this study adds to that conversation is imaging evidence that repeated cycles compound muscle loss in people not on medication at all. What it does not do is quantify anything about GLP-1 users, and no professional society has issued new guidance in response.
What the Study Cannot Tell You
The limitations are worth holding onto.
It is observational. People who cycle weight may differ from people who do not in ways the adjustments did not capture, including illness, medication use, and eating patterns.
The cohort was middle-aged adults at risk for knee osteoarthritis, a group that may be less mobile and more prone to muscle loss than the general population. The findings may not transfer cleanly to younger or healthier people.
Thigh muscle volume is a reasonable proxy for overall skeletal muscle but is not the same as measured strength, physical function, or fall risk. The study did not report those outcomes.
And four years is the observation window. Longer follow-up would be needed to say anything about permanence.
What to Do With This If You Are Losing Weight
Nobody should stop a prescribed medication because of this study. That includes GLP-1 drugs taken for diabetes or cardiovascular risk, where the consequences of stopping are concrete and immediate.
The reasonable response is to make muscle preservation part of any weight-loss plan rather than an afterthought. That generally means resistance training at least twice weekly and adequate protein intake, and it is worth asking a clinician or a registered dietitian what those targets should be for your age, kidney function and medical history rather than adopting numbers from an article.
People who anticipate a coverage or cost interruption in a weight-loss medication can raise it with a prescriber before it happens, since an unplanned stop and restart is the pattern this research suggests is worth avoiding.
Simple in-office measures of muscle function, including grip strength and a chair-stand test, are available and inexpensive if you want a baseline.
Researchers will need studies that follow people through medication-driven weight loss and regain, with imaging, to answer the question this one raised. That work has not been done.
Frequently Asked Questions
What did the study find? Adults whose weight repeatedly fluctuated over four years lost about 3.7% of thigh muscle volume, compared with about 1% among adults whose weight stayed relatively stable.
Does this prove weight cycling causes muscle loss? No. This was an observational imaging study. It found an association after adjusting for several factors, but it cannot establish cause.
Was the muscle loss permanent? The study found the muscle had not returned within its four-year window. It did not follow participants long enough to establish permanence.
Did the study include people on GLP-1 drugs? No. No participant was taking a weight-loss medication. The connection to GLP-1 use is a question the lead author raised, not something the study measured.
Who was studied? 1,433 middle-aged adults enrolled in the Osteoarthritis Initiative, a cohort of people at elevated risk for knee osteoarthritis. Results may not apply equally to younger or healthier populations.
Should someone stop a weight-loss medication because of this? No. Do not stop or change a prescribed medication based on a news report. Discuss any concerns with the prescribing clinician.
How can someone protect muscle during weight loss? Resistance training and adequate protein intake are the established approaches. Specific targets should come from a clinician or registered dietitian, not from an article.
